Home » Topics » BioWorld Science

BioWorld Science
RSS

Idorsia Pharmaceuticals discovers Kv7 potassium channel activators

Jan. 19, 2022

ATR kinase blockade useful for treating pancreatic ductal adenocarcinoma

Jan. 19, 2022

MAO mutant zebrafish exhibit abnormal brain development

Jan. 19, 2022

SUW-133 diminishes HIV viral load in vivo

Jan. 18, 2022

Avacta selects FAP-targeted proteasome inhibitor for preclinical development

Jan. 18, 2022

4basebio and eTheRNA collaborate to evaluate linear DNA for mRNA production

Jan. 18, 2022

ZIP8 found to correlate with severe rheumatoid arthritis

Jan. 18, 2022

MCC-1381, a pan-HDAC inhibitor with promising anticancer activity

Jan. 18, 2022

EZH2 as a promising therapeutic target for prostate cancer

Jan. 18, 2022

Ono and Neurimmune expand drug discovery collaboration for neurodegenerative diseases

Jan. 18, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Molecular signatures show subtypes in neurodegenerative diseases
BioWorld Science
Parkinson’s disease is a progressive neurodegenerative disorder best known for its motor symptoms. However, a proportion of patients also develop dementia as the...